Skip to main content
SleepCited

Demir için Huzursuz Bacak Sendromu

A

65 çalışmaya (5 meta-analyses), toplam 24,923 katılımcıyla dayanmaktadır. 34/65 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Drestless\u002Dleg\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Iron supplementation is well-supported by research for reducing restless leg syndrome symptoms, especially in people with confirmed iron deficiency.

  • 65 studies with nearly 25,000 participants — one of the most studied supplement-condition pairs
  • A 2025 meta-analysis confirmed the efficacy and safety of iron for RLS
  • Iron deficiency is a recognized major risk factor for restless leg syndrome
  • IV iron (ferric carboxymaltose) shows particularly strong results in clinical trials

Key Study Findings

review
[Restless leg syndrome. Diagnosis and treatment].
Dose: various vs: Placebo Etki: None None
case-control n=90
Restless Leg Syndrome and Association with Serum NT Pro-CNP.
Dose: None vs: Placebo Etki: NT pro-CNP significantly lower in RLS vs controls; sensitivity 80%, specificity 88.9%; serum iron lo None
Cohort Study n=58 Open-label
Efficacy and safety of intravenous iron in patients with restless legs syndrome with normal serum …
Dose: 1000 mg ferric carboxymaltose vs: Group A (ferritin <100) vs Group B (ferritin 100-300) Outcome: IRLS severity scale score change Etki: None None

Popülasyon: RLS patients with serum ferritin <300 µg/L

review
Restless Leg Syndrome and Pregnancy.
Dose: iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) vs: Placebo Etki: None None
review
[Restless Legs Syndrome].
Dose: dopamine agonists, iron supplementation, alpha-2-delta ligands vs: Placebo Etki: None None

Key Statistics

173

Çalışmalar

36638

Katılımcılar

Mixed

A

Derece

Referenced Papers

Revista de neurologia None 8 atıf
Handbook of clinical … 2025
Southern medical journal 2025
Brain and nerve … 2025
Tremor and other … 2023 32 atıf
Sleep medicine clinics 2023 14 atıf
Continuum (Minneapolis, Minn.) 2023 2 atıf
Australian journal of … 2023
Experimental neurology 2022 36 atıf
Antioxidants (Basel, Switzerland) 2022 13 atıf
MMW Fortschritte der … 2022 1 atıf
Nature reviews. Disease … 2021 163 atıf
Neurotherapeutics : the … 2021 162 atıf
Current neuropharmacology 2021 13 atıf
Sleep medicine clinics 2021 11 atıf
Sleep medicine clinics 2021 9 atıf
The International journal … 2021 6 atıf
Sleep medicine clinics 2021 5 atıf
International journal of … 2020 34 atıf
Continuum (Minneapolis, Minn.) 2020 17 atıf
La Revue de … 2020 3 atıf
Der Nervenarzt 2020 2 atıf
The lancet. Diabetes … 2020 2 atıf
The Neuroscientist : … 2019 120 atıf
Current neurology and … 2019 68 atıf
The Cochrane database … 2019 62 atıf
Sleep medicine reviews 2019 47 atıf
Advances in pharmacology … 2019 27 atıf
Advances in pharmacology … 2019 20 atıf
Advances in pharmacology … 2019 3 atıf
Advances in pharmacology … 2019 2 atıf
International review of … 2018 24 atıf
Revue neurologique 2018 11 atıf
Pediatric annals 2018 5 atıf
Missouri medicine 2018
FP essentials 2017 11 atıf
Clinical medicine (London, … 2016 44 atıf
Acta dermatovenerologica Croatica … 2016 6 atıf
Wiener medizinische Wochenschrift … 2016 2 atıf
Biometals : an … 2016
Sleep medicine clinics 2015 158 atıf
Sleep medicine reviews 2015 38 atıf
Sleep medicine clinics 2015 29 atıf
Critical care clinics 2015 28 atıf
Movement disorders : … 2015
Parkinsonism & related … 2014 78 atıf
Handbook of clinical … 2014 52 atıf
Nephro-urology monthly 2014 43 atıf
The Cochrane database … 2012 31 atıf
American family physician 2012
Indian journal of … 2011 75 atıf
Handbook of clinical … 2011 8 atıf
Current opinion in … 2010
Journal of internal … 2009 125 atıf
Brain and nerve … 2009
The Israel Medical … 2008 61 atıf
Acta medica portuguesa 2008
American family physician 2008
The Nurse practitioner 2008
American journal of … 2007 61 atıf
American journal of … 2006 23 atıf
The Lancet. Neurology 2005 215 atıf
Progress in neurobiology 2005 47 atıf
Current neurology and … 2005 15 atıf
Neurologic clinics 2005 13 atıf
Primary care 2005 2 atıf
Current opinion in … 2005
Neurology 2004 386 atıf
Annals of neurology 2004 183 atıf
Sleep medicine reviews 2001 48 atıf
The Journal of … 2001 7 atıf
Mayo Clinic proceedings 1997 30 atıf
The American Journal … 1996 1 atıf
Mayo Clinic proceedings 1990 68 atıf
Canadian Medical Association … 1967

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

rls:
65 mg elemental iron if ferritin <75
general:
18 mg/day (women)

Üst sınır: 45 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
various -- Positive --
None -- Positive 90
1000 mg ferric carboxymaltose -- Positive 58
iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) -- Positive --
dopamine agonists, iron supplementation, alpha-2-delta ligands -- Positive --
None -- Neutral --
None -- Mixed --
None -- Positive --

En iyi alım zamanı: On an empty stomach with vitamin C; take in the morning, not before bed

Safety & Side Effects

Bildirilen Yan Etkiler

  • Constipation
  • Nausea
  • Stomach pain
  • Dark stools
  • Iron overload risk (hemochromatosis)

Bilinen Etkileşimler

  • Antacids and PPIs — reduce iron absorption
  • Levothyroxine — iron reduces thyroid medication absorption
  • Antibiotics (tetracyclines, fluoroquinolones) — mutual absorption reduction
  • Calcium supplements — take separately by 2 hours

Tolere edilebilir üst alım: 45 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Demir help with Huzursuz Bacak Sendromu?
Based on 173 studies with 36,638 participants, there is strong evidence from multiple clinical trials that Demir may support Huzursuz Bacak Sendromu management. Our evidence grade is A (Strong Evidence).
How much Demir should I take for Huzursuz Bacak Sendromu?
Studies have used various dosages. A commonly studied range is 65 mg elemental iron if ferritin <75. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Demir?
Reported side effects may include Constipation, Nausea, Stomach pain, Dark stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Demir and Huzursuz Bacak Sendromu?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 173 peer-reviewed studies with 36,638 total participants. The overall direction of effect is mixed.

Related Evidence

Şu durum için diğer içerikler: Huzursuz Bacak Sendromu

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.